Abstract
Vancomycin is a glycopeptide antibiotic used to treat serious infections with gram-positive bacteria that are resistant to other antibiotics. Patients receiving haemodialysis (HD) via central venous catheters are at an increased risk of gram-positive bacterial infections. Strains of staphylococci and enterococci resistant or only partially sensitive to vancomcyin have developed; therefore, appropriate controlled use of vancomycin is essential.
| Original language | English |
|---|---|
| Pages (from-to) | 8-9 |
| Number of pages | 2 |
| Journal | British Journal of Renal Medicine |
| Volume | 19 |
| Issue number | 1 |
| Publication status | Published - May 2014 |